Literature DB >> 20573669

Multiple strains of non-tuberculous mycobacteria in a patient with cystic fibrosis.

Sarah M N Brown1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20573669      PMCID: PMC2905029          DOI: 10.1258/jrsm.2010.s11009

Source DB:  PubMed          Journal:  J R Soc Med        ISSN: 0141-0768            Impact factor:   5.344


× No keyword cloud information.
  22 in total

1.  Management of non-tuberculous mycobacteria in patients with cystic fibrosis.

Authors:  Lynne M Quittell
Journal:  Paediatr Respir Rev       Date:  2004       Impact factor: 2.726

2.  A single 16S ribosomal RNA substitution is responsible for resistance to amikacin and other 2-deoxystreptamine aminoglycosides in Mycobacterium abscessus and Mycobacterium chelonae.

Authors:  T Prammananan; P Sander; B A Brown; K Frischkorn; G O Onyi; Y Zhang; E C Böttger; R J Wallace
Journal:  J Infect Dis       Date:  1998-06       Impact factor: 5.226

Review 3.  Mycobacterium abscessus and other nontuberculous mycobacteria: evolving respiratory pathogens in cystic fibrosis: a case report and review.

Authors:  Don Hayes
Journal:  South Med J       Date:  2005-06       Impact factor: 0.954

4.  Age-related prevalence and distribution of nontuberculous mycobacterial species among patients with cystic fibrosis.

Authors:  Catherine Pierre-Audigier; Agnès Ferroni; Isabelle Sermet-Gaudelus; Muriel Le Bourgeois; Catherine Offredo; Hoang Vu-Thien; Brigitte Fauroux; Patricia Mariani; Anne Munck; Edouard Bingen; Didier Guillemot; Gilles Quesne; Véronique Vincent; Patrick Berche; Jean-Louis Gaillard
Journal:  J Clin Microbiol       Date:  2005-07       Impact factor: 5.948

5.  Nontuberculous mycobacteria. II: nested-cohort study of impact on cystic fibrosis lung disease.

Authors:  Kenneth N Olivier; David J Weber; Ji-Hyun Lee; Allison Handler; Gail Tudor; Paul L Molina; Joseph Tomashefski; Michael R Knowles
Journal:  Am J Respir Crit Care Med       Date:  2002-11-14       Impact factor: 21.405

6.  Nontuberculous mycobacteria in cystic fibrosis associated with allergic bronchopulmonary aspergillosis and steroid therapy.

Authors:  H Mussaffi; J Rivlin; I Shalit; M Ephros; H Blau
Journal:  Eur Respir J       Date:  2005-02       Impact factor: 16.671

7.  Mycobacterium abscessus infection in cystic fibrosis. Colonization or infection?

Authors:  A R Cullen; C L Cannon; E J Mark; A A Colin
Journal:  Am J Respir Crit Care Med       Date:  2000-02       Impact factor: 21.405

Review 8.  Nontuberculous mycobacterial pulmonary disease in cystic fibrosis.

Authors:  K N Olivier; J R Yankaskas; M R Knowles
Journal:  Semin Respir Infect       Date:  1996-12

9.  Non-tuberculous mycobacteria in cystic fibrosis.

Authors:  J K Torrens; P Dawkins; S P Conway; E Moya
Journal:  Thorax       Date:  1998-03       Impact factor: 9.139

10.  Interaction between mycobacteria and mucus on a human respiratory tissue organ culture model with an air interface.

Authors:  A M Middleton; M V Chadwick; A G Nicholson; R Wilson; D J Thornton; S Kirkham; J K Sheehan
Journal:  Exp Lung Res       Date:  2004 Jan-Feb       Impact factor: 2.459

View more
  1 in total

Review 1.  Non-tuberculous mycobacteria in cystic fibrosis.

Authors:  Uta G Hill; R Andres Floto; Charles S Haworth
Journal:  J R Soc Med       Date:  2012-06       Impact factor: 5.344

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.